Impacts of Gastrointestinal Disease in Canada
Economy
Data from the Public Health Agency of Canada's Economic burden of illness in Canada (EBIC) 2000 provide a conservative estimate of $2.5 billion in year 2000 CAD for the total cost of diabetes, excluding cost associated with diabetes complications
According to a study conducted in 1998, the total costs of diabetes were 3.6 times higher when the costs associated with long-term complications of diabetes (including neurological disease, peripheral vascular disease, cardiovascular disease, kidney disease, and eye disease) were included
At the national level, EBIC 2000 estimated that the total direct health care costs of diabetes were $769.4 million in year 2000 CAD, for the primary management of diabetes only
Family
Premature death and funeral costs can be a burden to the family of those suffering with a gastrointestinal disease
Health Care System
In 2008/09, adults aged 20 to 49 years with diabetes saw a family physician about twice as often as those without diabetes, and a specialist two to three times more often
In 2006/07, the average length of stay in hospital for younger adults with diabetes (aged 20 to 54 years) was four to six times the number of days stayed by individuals without diabetes
Hospitalizations in children and youth with diabetes were almost seven times higher than in children and youth without diabetes
Employment
If suffering from a gastrointestinal disease you will most likely need time off work from time to time
Individual
In 2007, the CCHS collected additional data from individuals who self-reported a diagnosis of diabetes, and found that 81% of respondents indicated that their HbA1C levels had been checked by a physician in the past year
Individuals who reported using insulin were more likely to have their HbA1C levels tested than their counterparts who reported not using insulin (87% versus 80%)
In 2009-2010, 89.7% of individuals aged 12 to 19 years and 85.1% of individuals aged 20 years or older with diabetes reported being on at least one oral medication, insulin, or both